Cognition

perspective

B2B Prospecting

The Hidden Data Trap in B2B Prospecting: Why the Data Crackdown is Just the Beginning

The Calm Before the Fracture  A quiet but seismic shift is underway in B2B lead generation—and many organizations don’t yet realize their foundations are starting to crack.  Recent platform enforcement actions have seen major data providers vanish from LinkedIn almost overnight. Tools that fueled thousands of prospecting pipelines – automated scrapers, Chrome extensions, and plug-ins, …

The Hidden Data Trap in B2B Prospecting: Why the Data Crackdown is Just the Beginning Read More »

Revenue Blind Spots

The Revenue Blind Spots: Why Event Companies Are Missing 40% of Their Growth Opportunities

Cognition Solutions analysis reveals some striking patterns in the B2B events landscape: companies achieving record post-pandemic recovery are still missing up to 40% of their revenue potential. This isn’t about untapped markets or new event formats – it’s about Revenue Blind Spots – revenue opportunities hiding in plain sight within existing portfolios. 📊 Three critical …

The Revenue Blind Spots: Why Event Companies Are Missing 40% of Their Growth Opportunities Read More »

ESG in Healthcare Procurement

ESG in Healthcare Procurement: What It Means for Medical Device and MedTech Companies

📉 The $3.8 Billion Wake-Up Call: A Shift in Hospital Procurement In 2023, a major U.S. hospital network canceled over $3.8 billion in long-term supply contracts with medical device manufacturers—not due to cost, but ESG misalignment. The suppliers, while clinically competitive, failed to meet new environmental and labor transparency criteria that the health system had …

ESG in Healthcare Procurement: What It Means for Medical Device and MedTech Companies Read More »

Beyond Drug Discovery: Predictive Analytics for Biotech B2B Lead Generation

Beyond Drug Discovery: Predictive Analytics for Biotech B2B Lead Generation

Revolutionizing Biotech B2B Sales: The Power of Predictive Analytics In a boardroom filled with biotech executives, the conversation is no longer just about groundbreaking therapies—it’s about precision-targeted B2B lead generation. Imagine a world where contract research organizations (CROs), contract manufacturing organizations (CMOs), and biotech investors don’t just stumble upon opportunities but predict and capture them …

Beyond Drug Discovery: Predictive Analytics for Biotech B2B Lead Generation Read More »

The Future of Petrochemical in a Decarbonized World: What Competitive Intelligence Tells Us

The Future of Petrochemicals in a Decarbonized World: What Competitive Intelligence Tells Us

A Wake-Up Call: The $2 Trillion Disruption No One Saw Coming In 2023, a leading petrochemical giant faced an existential crisis. A disruptive newcomer—armed with AI-driven green chemistry and a strategic partnership with a bio-based materials startup—captured 15% of its core market in just two years. By the time the incumbent reacted, its R&D cycles …

The Future of Petrochemicals in a Decarbonized World: What Competitive Intelligence Tells Us Read More »

Regulatory Compliance in Pharma: Proactive Risk Mitigation Through Media Monitoring

Regulatory Compliance in Pharma: Proactive Risk Mitigation Through Media Monitoring

The Hidden Cost of Non-Compliance: A Lesson from the Headlines In 2019, a leading pharmaceutical company found itself in regulatory crosshairs after an investigative journalist exposed potential data discrepancies in its clinical trial reporting. The story spread like wildfire across media outlets, catching the attention of regulators worldwide. The company faced an immediate stock price …

Regulatory Compliance in Pharma: Proactive Risk Mitigation Through Media Monitoring Read More »

Cognition
Scroll to Top